TAGLN2 and cancer: However, a few reports demonstrated that transgelin-2 instead inhibits the motility of cancer cells, such as hepatocarcinoma cells, by suppressing actin polymerization (Leung et al., 2011; Yoshida et al., 2013; Yang et al., 2019).